IceCure Medical Ltd. Announces Breakthrough Study: ProSense® Cryoablation Significantly Reduces Pain in Abdominal Wall Endometriosis with High Efficacy
Reuters
Sep 04
<a href="https://laohu8.com/S/ICCM">IceCure Medical Ltd.</a> Announces Breakthrough Study: ProSense® Cryoablation Significantly Reduces Pain in Abdominal Wall Endometriosis with High Efficacy
IceCure Medical Ltd. has announced findings from an independent study evaluating the efficacy and safety of its ProSense® cryoablation technology in treating abdominal wall endometriosis (AWE). The study, conducted at Nîmes University Hospital in France and published in the Journal of Personalized Medicine, involved 14 patients with 23 AWE lesions. Results demonstrated significant pain relief, with median pain scores declining from 8/10 to 0/10 at a three-month follow-up. The procedure was shown to have high efficacy, with MRI confirming complete coverage of the ablation zone and no reported complications. The study supports ProSense® as a viable minimally invasive treatment option for AWE, with potential implications for its commercial application in multiple gynecological indications.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO65499) on September 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.